Table 2.
Summary of variables divided into perfect, substantial, and moderate agreement
| Variables | Perfect agreement 100% |
Substantial agreement 75–99.9% |
Moderate agreement 50–74.99% |
|
|---|---|---|---|---|
| Patient characteristics | ||||
| 1. | Nationality | X | ||
| 2. | Patient ID no. | X | ||
| 3. | Healthcare institution | X | ||
| 4. | Hospital ID | X | ||
| 5. | Initials | X | ||
| 6. | Prefix | X | ||
| 7. | Surname | X | ||
| 8. | Date of birth | X | ||
| 9. | Sex | X | ||
| 10 | Date of death | X | ||
| Prior bariatric history | ||||
| 11. | Hospital ID | X | ||
| 12. | Prior metabolic or bariatric procedure | X | ||
| 13. | Prior type of gastric bypass | X | ||
| 14. | Prior type of malabsorptive procedure | X | ||
| 15. | Prior type of other bariatric procedures | X | ||
| Screening | ||||
| 16. | Healthcare institution | X | ||
| 17. | Hospital ID | X | ||
| 18. | Date of consultancy | X | ||
| 19. | Height | X | ||
| 20. | Weight | X | ||
| 21. | Hypertension (diagnosis) | X | ||
| 22. | Diabetes mellitus (diagnosis) | X | ||
| 23. | Details diabetes mellitus | X | ||
| 24. | HbA1c (mmol/mol) | X | ||
| 25. | Dyslipidemia | X | ||
| 26. | GERD (diagnosis) | X | ||
| 27. | OSAS (diagnosis) | X | ||
| 28. | Osteoarthritis (diagnosis) | X | ||
| 29. | Peripheral vascular disease/aneurysm aorta | X | ||
| 30. | Liver disease | X | ||
| 31. | Mobility | X | ||
| 32. | Increased risk pulmonary Embolism | X | ||
| 33. | PCOS | X | ||
| 34. | Depression | X | ||
| 35. | Smoking | X | ||
| Operation | ||||
| 36. | Healthcare institution | X | ||
| 37. | Hospital ID | X | ||
| 38. | Preoperative weight | X | ||
| 39. | ASA classification | X | ||
| 40. | Date of operation | X | ||
| 41. | Surgical procedure (primary/two-stage/revision) | X | ||
| 42. | Operative approach | X | ||
| 43. | Bariatric procedure | X | ||
| 44. | Surgeon ID | X | ||
| 45. | Date of discharge | X | ||
| 46. | Type of technique gastric band | X | ||
| 47. | Fixation gastric band | X | ||
| 48. | Type malabsorptive | X | ||
| 49. | Type gastric bypass | X | ||
| 50. | Biliopancreatic limb length | X | ||
| 51. | Alimentary limb length | X | ||
| 52. | Closure Petersen’s space | X | ||
| 53 | Closure hernia jejuno-jejunostomy | X | ||
| 54. | Type gastric band (brand) | X | ||
| 55. | Common limb length | X | ||
| 56. | Bougie size | X | ||
| 57. | Technique of pouch excision | X | ||
| 58. | Distance from pylorus | X | ||
| 59. | Details of other operation(s) | X | ||
| 60. | Combined operation | X | ||
| 61. | Suture material | X | ||
| 62. | Ante-colic/retro-colic | X | ||
| Complication | ||||
| 63. | Healthcare institution | X | ||
| 64. | Hospital ID | X | ||
| 65. | Date of complication | X | ||
| 66. | Period the complication occurred | X | ||
| 67. | Date of re-admission | X | ||
| 68. | Date of discharge after re-admission | X | ||
| 69. | Type of (re)intervention | X | ||
| 70. | Operative approach (re)intervention | X | ||
| 71. | Patient status at discharge | X | ||
| 72. | Gastrointestinal perforation | X | ||
| 73. | Bleeding | X | ||
| 74. | Splenic injury | X | ||
| 75. | Source of bleeding | X | ||
| 76. | Surgical complications | X | ||
| 77. | Leak | X | ||
| 78. | Post-operative complications | X | ||
| 79. | Gastric complication | X | ||
| 80. | Stricture | X | ||
| 81. | Electrolyte disorder | X | ||
| 82. | Hepatobiliary problems | X | ||
| 83 | CBD stones | X | ||
| 84. | Band problems | X | ||
| 85. | Pouch dilatation/band slippage | X | ||
| 86. | Band erosion | X | ||
| 87. | Port/band infection | X | ||
| 88. | Other complications (including cardiac, pulmonary and other) | X | ||
| 89. | Incisional hernia | X | ||
| 90. | Intestinal obstruction | X | ||
| 91. | Petersen’s hernia | X | ||
| 92. | Malnutrition/enteral feeding | X | ||
| 93. | Post-op vomiting/nausea | X | ||
| 94. | Patient discharge to (home/revalidation center) | X | ||
| Follow-up | ||||
| 95. | Healthcare institution | X | ||
| 96. | Hospital ID | X | ||
| 97. | Date of follow-up | X | ||
| 98. | Weight | X | ||
| 99. | Hypertension status | X | ||
| 100. | Medical treatment hypertension | X | ||
| 101. | Diabetes mellitus status | X | ||
| 102. | HbA1c (mmol/mol) | X | ||
| 103. | Medical treatment diabetes mellitus | X | ||
| 104. | Dyslipidemia status | X | ||
| 105. | GERD status | X | ||
| 106. | Medical treatment GERD | X | ||
| 107. | OSAS status | X | ||
| 108. | Medical treatment OSAS | X | ||
| 109. | Osteoarthritis | X | ||
| 110. | Medical treatment osteoarthritis | X | ||
| 111. | Clinical malnutrition | X | ||
| 112. | Vitamins and micro-elements intake | X | ||
ID, identity document; HbA1c, hemoglobin A1c; GERD, gastroesophageal reflux disease; OSAS, obstructive sleep apnea syndrome; PCOS, polycystic ovary syndrome; ASA, American Society of Anesthesiologists; CBD stones, common bile duct stones
Adolescent section of the NBSR and the pre-operative work-up section of OGA are not included in the list of common data elements due to registration-specific variables